Eli Lilly Says Other Antibody Trials Ongoing After NIH Pause

(Bloomberg) -- Eli Lilly & Co. said it is reviewing safety data that caused federal researchers to pause a trial of the company’s Covid-19 antibody in hospitalized patients. In the meantime, other ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.